Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$8.64 USD
+0.39 (4.66%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $8.66 +0.02 (0.23%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Anika Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANIK 8.64 +0.39(4.66%)
Will ANIK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ANIK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANIK
Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates
uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates
ANIK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock?
Company News for May 12, 2025
Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates
Other News for ANIK
Anika Therapeutics (ANIK) Target Price Reduced Amidst Market Skepticism
Anika Therapeutics (ANIK): Analyst Updates Price Target | ANIK Stock News
Anika Therapeutics price target lowered by $4 at Barrington, here's why
Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
12 Health Care Stocks Moving In Wednesday's Intraday Session